Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,05 CAD | -2,38% | -0,49% | -24,07% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
William Radvak
FOU | Founder | 61 | 19-01-17 |
Michael Kelly
CEO | Chief Executive Officer | 59 | 10-04-23 |
Bill Adams
DFI | Director of Finance/CFO | 62 | 24-02-20 |
Daniel Mikol
CTO | Chief Tech/Sci/R&D Officer | - | 05-05-21 |
Adam Rogers
BRD | Director/Board Member | - | 14-07-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Randall Kaye
BRD | Director/Board Member | 62 | 28-10-20 |
Brian Bayley
BRD | Director/Board Member | 71 | 16-05-18 |
William Radvak
FOU | Founder | 61 | 19-01-17 |
Michael Kelly
CEO | Chief Executive Officer | 59 | 10-04-23 |
Harold Punnett
FOU | Founder | 67 | 19-01-17 |
John Thompson
BRD | Director/Board Member | 57 | 13-04-22 |
John Ruffolo
BRD | Director/Board Member | - | 17-10-23 |
Glenn Ives
BRD | Director/Board Member | 62 | 01-09-21 |
Adam Rogers
BRD | Director/Board Member | - | 14-07-22 |
Director/Board Member | - | 01-09-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 69 927 649 | 53 893 753 ( 77,07 %) | 0 | 77,07 % |
Bedrijfsgegevens
NervGen Pharma Corp.
112-970 Burrard Street Unit 1290
V6Z 2R4, Vancouver
+778-731-1711
http://www.nervgen.comSector
Verkoop per regio
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-24,07% | 107 mln. | |
+0,67% | 42,19 mld. | |
+44,30% | 40,15 mld. | |
-6,20% | 28,31 mld. | |
+6,55% | 24,63 mld. | |
-21,66% | 18,2 mld. | |
+29,96% | 12,01 mld. | |
-1,57% | 11,76 mld. | |
+16,03% | 10,4 mld. | |
-4,80% | 9,94 mld. |
- Beurs
- Aandelen
- Koers NGEN
- Onderneming NervGen Pharma Corp.